BVS Reports $157.9M Q4 Revenue, $0.21 GAAP EPS, $0.24 Adjusted EPS, $38M Cash Flow, 2026 Guidance Outlook
Bioventus Inc. Class A Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $7.93
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS